Old Web
English
Sign In
Acemap
>
authorDetail
>
J. J. Grous
J. J. Grous
Medicine
Pathology
non-small cell lung cancer (NSCLC)
Epidermal growth factor receptor
Gefitinib
3
Papers
43
Citations
0.02
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase III study of sustained release granisetron (APF530) compared to palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV)
2009
Journal of Clinical Oncology
J. J. Grous
E. Riegel
Nashat Y. Gabrail
V. Charu
Roberto Arevalo Araujo
Ronald Yanagihara
A. Nguyen
P. Robertson
B. Cooper
Erin OBoyle
J. Barr
Show All
Source
Cite
Save
Citations (3)
GCS-100, a galectin-3 antagonist, in refractory solid tumors: A phase I study
2006
Journal of Clinical Oncology
J. J. Grous
C H Redfern
D Mahadevan
J Schindler
Show All
Source
Cite
Save
Citations (12)
Final survival and safety results for 21,064 non-small-cell lung cancer (NSCLC) patients who received compassionate use gefitinib in a U.S. expanded access program (EAP)
2004
Journal of Clinical Oncology
J. Ochs
J. J. Grous
K. L. Warner
Show All
Source
Cite
Save
Citations (28)
1